X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Orchid Chemicals with Aventis Pharma - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ORCHID PHARMA LTD vs SANOFI INDIA - Comparison Results

ORCHID PHARMA LTD    Change

Orchid Chemicals & Pharmaceuticals Ltd. (Orchid) is today a globally recognized, integrated pharmaceutical company with core competencies in the development and manufacture of Active Pharmaceutical Ingredients (APIs) and Finished Dosage Forms as well... More

SANOFI INDIA 
   Change

Sanofi India (the erstwhile Aventis Pharma), the 60% subsidiary of Sanofi-Aventis SA, France, is one of the largest pharma MNCs in India with a turnover of over Rs 13.2 bn in CY11. Domestic sales constituted 81% of total sales in CY11 and exports con... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ORCHID PHARMA LTD SANOFI INDIA ORCHID PHARMA LTD/
SANOFI INDIA
 
P/E (TTM) x -0.7 30.0 - View Chart
P/BV x 0.5 5.3 10.1% View Chart
Dividend Yield % 0.0 1.7 -  

Financials

 ORCHID PHARMA LTD   SANOFI INDIA
EQUITY SHARE DATA
    ORCHID PHARMA LTD
Sep-13
SANOFI INDIA
Dec-16
ORCHID PHARMA LTD/
SANOFI INDIA
5-Yr Chart
Click to enlarge
High Rs1944,560 4.3%   
Low Rs354,400 0.8%   
Sales per share (Unadj.) Rs276.51,028.5 26.9%  
Earnings per share (Unadj.) Rs-79.2129.0 -61.4%  
Cash flow per share (Unadj.) Rs-43.5186.0 -23.4%  
Dividends per share (Unadj.) Rs068.00 0.0%  
Dividend yield (eoy) %01.5 0.0%  
Book value per share (Unadj.) Rs53.9753.6 7.2%  
Shares outstanding (eoy) m70.4523.03 305.9%   
Bonus/Rights/Conversions ESOP--  
Price / Sales ratio x0.44.4 9.5%   
Avg P/E ratio x-1.434.7 -4.2%  
P/CF ratio (eoy) x-2.624.1 -10.9%  
Price / Book Value ratio x2.15.9 35.7%  
Dividend payout %052.7 0.0%   
Avg Mkt Cap Rs m8,067103,174 7.8%   
No. of employees `0002.83.6 77.3%   
Total wages/salary Rs m2,5273,592 70.4%   
Avg. sales/employee Rs Th6,956.16,537.7 106.4%   
Avg. wages/employee Rs Th902.5991.4 91.0%   
Avg. net profit/employee Rs Th-1,993.0819.8 -243.1%   
INCOME DATA
Net Sales Rs m19,47723,686 82.2%  
Other income Rs m407708 57.5%   
Total revenues Rs m19,88424,394 81.5%   
Gross profit Rs m1,1035,281 20.9%  
Depreciation Rs m2,5191,313 191.9%   
Interest Rs m5,22715 34,845.3%   
Profit before tax Rs m-6,2364,661 -133.8%   
Minority Interest Rs m200-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m5110-   
Tax Rs m-1251,691 -7.4%   
Profit after tax Rs m-5,5802,970 -187.9%  
Gross profit margin %5.722.3 25.4%  
Effective tax rate %2.036.3 5.5%   
Net profit margin %-28.712.5 -228.5%  
BALANCE SHEET DATA
Current assets Rs m11,01415,673 70.3%   
Current liabilities Rs m32,0606,678 480.1%   
Net working cap to sales %-108.138.0 -284.5%  
Current ratio x0.32.3 14.6%  
Inventory Days Days9576 124.9%  
Debtors Days Days3422 150.4%  
Net fixed assets Rs m29,4408,098 363.5%   
Share capital Rs m705230 305.9%   
"Free" reserves Rs m2,04317,088 12.0%   
Net worth Rs m3,80017,356 21.9%   
Long term debt Rs m9,0180-   
Total assets Rs m46,51025,400 183.1%  
Interest coverage x-0.2311.7 -0.1%   
Debt to equity ratio x2.40-  
Sales to assets ratio x0.40.9 44.9%   
Return on assets %-0.811.8 -6.5%  
Return on equity %-146.917.1 -858.2%  
Return on capital %-3.726.9 -13.9%  
Exports to sales %37.924.5 154.7%   
Imports to sales %22.628.0 80.9%   
Exports (fob) Rs m7,3785,801 127.2%   
Imports (cif) Rs m4,4066,627 66.5%   
Fx inflow Rs m7,5137,145 105.2%   
Fx outflow Rs m5,6496,846 82.5%   
Net fx Rs m1,865299 623.6%   
CASH FLOW
From Operations Rs m1,6823,226 52.1%  
From Investments Rs m-9,860-1,555 634.1%  
From Financial Activity Rs m6,644-1,818 -365.4%  
Net Cashflow Rs m-1,535-147 1,044.2%  

Share Holding

Indian Promoters % 32.3 0.0 -  
Foreign collaborators % 0.0 60.4 -  
Indian inst/Mut Fund % 4.6 14.4 31.9%  
FIIs % 3.3 14.6 22.6%  
ADR/GDR % 4.6 0.0 -  
Free float % 55.3 10.5 526.7%  
Shareholders   84,811 15,184 558.6%  
Pledged promoter(s) holding % 54.9 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ORCHID PHARMA LTD With:   SUN PHARMA  WYETH LTD  ABBOTT INDIA  FULFORD INDIA  DR. REDDYS LAB  

Compare ORCHID PHARMA LTD With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Finishes on a Flat Note; Dr Reddy's & Lupin Surge over 2%(Closing)

Indian share markets continued to trade just above the dotted line in the afternoon session in a lackluster day of trading. At the closing bell, the BSE Sensex closed higher by 33 points.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

The Most Important Innovation in Finance Since Gold Coins(Vivek Kaul's Diary)

Aug 10, 2017

Bill connects the dots...between money and growth, real money and real resources, gold and cryptocurrencies...and between gold, cryptocurrencies, and time.

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

5 Steps To Become Financially Independent(Outside View)

Aug 16, 2017

Ensure your financial Independence, and pledge to start the journey towards financial freedom today!

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ORCHID PHARMA LTD SHARE PRICE


Aug 22, 2017 (Close)

TRACK ORCHID PHARMA LTD

  • Track your investment in ORCHID PHARMA LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ORCHID PHARMA LTD

ORCHID PHARMA LTD 8-QTR ANALYSIS

COMPARE ORCHID PHARMA LTD WITH

MARKET STATS